62
Views
25
CrossRef citations to date
0
Altmetric
Research Article

Methodology of the VECAT study: Vitamin E intervention in cataract and age-related maculopathy

, , , , , , , & show all
Pages 195-208 | Published online: 08 Jul 2009

References

  • Eccarius S, Clark JI. Effect of aspirin and vitamin E on phase separation in calf lens homogenate. Ophthalm Res 1987;19(2):65–71.
  • Ross WM, Creighton MO, Inch WR, Trevithick JR. Radiation cataract formation diminished by vitamin E in rat lenses in vitro. Exp Eye Res 1983; 36(5):645–53.
  • Stewart-DeHaan PJ, Creighton MO, Sanwal M, Ross WM, Trevithick JR. Effects of vitamin E on cortical cataractogenesis induced by elevated temperature in intact rat lenses in medium 199. Exp Eye Res 1981; 32(I):51–60.
  • Linklater HA, Dzialoszynski T, McLeod HL, Sanford SE, Trevithick JR. Modelling cortical cataractogene-sis. XI. Vitamin C reduces gamma-crystallin leakage from lenses in diabetic rats. Exp Eye Res 199o;51(3): 241–7.
  • Ross WM, Creighton MO, Stewart-DeHaan PJ, Sanwal M, Hirst M, Trevithick JR. Modelling cortical cataractogenesis: 3. In vivo effects of vitamin E on cataractogenesis in diabetic rats. Can J Ophthalmol 1982; 17(2):61–6.
  • Varma SD, Beachy NA, Richards RD. Photoperoxidation of lens lipids: prevention by vitamin E. Photochem Photobiol 1982;36(6):623–6.
  • Creighton MO, Trevithick JR. Cortical cataract formation prevented by vitamin E and glutathione. Exp Eye Res 1979;29(6):689–93.
  • Creighton MO, Ross WM, Stewart-DeHaan PJ, Sanwal M, Trevithick JR. Modelling cortical cataractogenesis VII: Effects of vitamin E treatment on galactose-induced cataracts. Exp Eye Res 1985;40(2):213–22.
  • Creighton MO, Sanwal M, Stewart-DeHaan PJ, Trevithick JR. Modeling cortical cataractogenesis. V. Steroid cataracts induced by solumedrol partially prevented by vitamin E in vitro. Exp Eye Res 1983;37(0:65–76.
  • Augusteyn RC. Protein modification in cataract; possible oxidative mechanisms. In: Duncan G, editor. Mechanisms of cataract formation in the human lens. London: Academic Press, 1981.
  • Truscott RJ, Augusteyn RC. Oxidative changes in human lens proteins during senile nuclear cataract formation. Biochim Biophys Acta 1977;492(0:43–52.
  • Varma SD, Srivastava VK, Richards RD. Photoperoxidation in lens and cataract formation: preventive role of superoxide dismutase, catalase and vitamin C. Ophthalm Res 1982;14(3):167–75.
  • Fecondo JV, Augusteyn RC. Superoxide dismutase, catalase and glutathione peroxidase in the human cataractous lens. Exp Eye Res 1983;36(0:15–23.
  • McNamara M, Augusteyn RC. The effects of hydrogen peroxide on lens proteins: a possible model for nuclear cataract. Exp Eye Res 1984;38(0:45–56.
  • Robertson JM, Donner AP, Trevithick JR. Vitamin E intake and risk of cataracts in humans. Ann NY Acad Sci 1989;570:372–82.
  • Knekt P, Heliovaara M, Rissanen A, Aromaa A, Aaran RK. Serum antioxidant vitamins and risk of cataract. Brit Med J 1992;3o5(6866):1392–4.
  • Robertson JM, Donner AP, Trevithick JR. A possible role for vitamins C and E in cataract prevention. Am J Clin Nutrit 1991;53(1 Suppl):3465-351S.
  • Jacques PF, Hartz SC, Chylack LT, Jr., McGandy RB, Sadowski JA. Nutritional status in persons with and without senile cataract: blood vitamin and mineral levels. Am J Clin Nutrit 1988;48(0:152–8.
  • Taylor A. Role of nutrients in delaying cataracts. Ann NY Acad Sci 1992; 669:111-23; discussion 123–4.
  • Jacques PF, Chylack LT Jr., McGandy RB, Hartz SC. Antioxidant status in persons with and without senile cataract. Arch Ophthalmol 1988; 106(3):337–40.
  • Jacques PF, Chylack LT Jr. Epidemiologic evidence of a role for the antioxidant vitamins and carotenoids in cataract prevention. Am J Clin Nutrit 1991;53(i Suppl):352S–355S.
  • Leske MC, Chylack LT Jr., Wu SY. The Lens Opacities Case-Control Study. Risk factors for cataract. Arch Ophthalmol 1991; I09(2):244–51.
  • Hankinson SE, Stampfer MJ, Seddon JM, et al. Nutrient intake and cataract extraction in women: a prospective study. Brit Med J 1992;305(6849): 335–9.
  • Leske MC, Wu SY, Hyman L, et al. Biochemical factors in the lens opacities. Case-control study. The Lens Opacities Case-Control Study Group. Arch Ophthalmol 1995;113(9): 1113–9.
  • Mares-Perlman JA, Klein BE, Klein R, Ritter LL. Relation between lens opacities and vitamin and mineral supplement use. Ophthalmology 1994; 1o1(2):315–25.
  • Rouhiainen P, Rouhiainen H, Salonen JT. Association between low plasma vitamin E concentration and progression of early cortical lens opacities. Am J Epidemiol 1996; 144(5):496–500.
  • Tavani A, Negri E, Lavecchia C. Food and nutrient intake and risk of cataract. Ann Epidemiol 1996;6(1): 41–6.
  • Seddon JM, Christen WG, Manson JE, et al. The use of vitamin supplements and the risk of cataract among US male physicians. Am J Publ Health 1994:84(5):788–92.
  • Vitale S, West S, Hallfrisch J, et al. Plasma antioxidants and risk of cortical and nuclear cataract. Epidemiology 1993:4(3): 195–203.
  • Xue AN, Cai QY, Wang SQ, et al. Antioxidant status in persons with and without senile lens changes. Biomed Environm Sci 1996;9(2-3):144–8.
  • Wong L, Ho SC, Coggon D, et al. Sunlight exposure, antioxidant status, and cataract in Hong Kong fishermen. J Epidemiol Commun Health 1993; 47(I):46–9.
  • Tissie G, Flangakis S, Missotten L, et al. Antioxidant activity of plasma from subjects with and without senile cataract. Doc Ophthalmol 1993;83(4):357–61.
  • West S, Vitale S, Hallfrisch J, et al. Are antioxidants or supplements protective for age-related macular degeneration? Arch Ophthalmol 1994; 112(2):222–7.
  • Anonymous. Antioxidant status and neovascular age-related macular degeneration. Eye Disease Case-Control Study Group [published errata appear in Arch Ophthalmol 1993; 111(9):1228, 1993;111(10):1366 and 1993;111(11):1499]. Arch Ophthalmol 1993;111(1):104–9.
  • Mares-Perlman JA, Brady WE, Klein R, et al. Serum antioxidants and agerelated macular degeneration in a population-based case-control study. Arch Ophthalmol 1995;113(12):1518–23.
  • Steinberg EP, Javitt JC, Sharkey PD, et al. The content and cost of cataract surgery. Arch Ophthalmol 1993; 111(8):1041–9.
  • Taylor HR, West SK, Rosenthal FS, et al. Effect of ultraviolet radiation on 1988;319(22):1429–33.
  • Livingston PM, Guest CS, Stanislavsky Y, et al. A populationbased estimate of cataract prevalence: the Melbourne Visual Impairment Project experience. Devel Ophthalmol 1994;26:1–6.
  • Ware JE Jr., Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. MedCare 1992;30(6):473–83.
  • Raven JC, Court JH, Raven J. Manual for Raven's Progressive Matrices and Vocabulary Scales. London: H.K. Lewis & Co. Ltd., 1986.
  • Steinberg EP, Tielsch JM, Schein OD, et al. The VF-14. An index of functional impairment in patients with cataract. Arch Ophthalmol 1994; 112(5):630–8.
  • Livingston PM, Carson CA, Stanislavsky YL, Lee SE, Guest CS, Taylor HR. Methods for a population-based study of eye disease: the Melbourne Visual Impairment Project. Ophthalm Epidemiol 1994; I(3):139–48.
  • Seddon JM, Sahagian CR, Glynn RJ, Sperduto RD, Gragoudas ES. Evaluation of an iris color classification system. The Eye Disorders Case-Control Study Group. Invest Ophthalmol Vis Sci 1990; 31(8):1592–8.
  • Bailey IL, Lovie JE. New design principles for visual acuity letter charts. Am J Optom Physiol Optics 1976:53(11):740–5.
  • Bird AC, Bressler NM, Bressler SB, et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol 1995:39(5):367–74.
  • Taylor HR, West SK. The clinical grading of lens opacities. Austr NZ J Ophthalmol 1989;17(0:81–6.
  • Bailey IL, Bullimore MA, Raasch TW, Taylor HR. Clinical grading and the effects of scaling. Invest Ophthalmol Vis Sci 1991;32(2):422–32.
  • The American Academy of Ophthalmology . Preferred Practice Pattern: Diabetic Retinopathy. San Francisco: American Academy of Ophthalmology, 1989:

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.